Amgen Inc.

Amgen Inc.verified

AMGN

Price:

$311.935

Market Cap:

$167.33B

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal nu...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1983-06-17

Stock Exchange

NASDAQ

Ticker

AMGN

The Enterprise Value as of June 2024 (TTM) for Amgen Inc. (AMGN) is 221.64B

According to Amgen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 221.64B. This represents a change of 21.55% compared to the average of 182.34B of the last 4 quarters.

Amgen Inc. (AMGN) Historical Enterprise Value (quarterly & annually)

How has AMGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Amgen Inc. over the last ten years is 161.85B. The current 221.64B Enterprise Value has changed 13.59% with respect to the historical average. Over the past ten years (40 quarters), AMGN's Enterprise Value was at its highest in in the December 2023 quarter at 207.76B. The Enterprise Value was at its lowest in in the June 2014 quarter at 118.82B.

Quarterly (TTM)
Annual

Average

161.85B

Median

157.16B

Minimum

140.72B

Maximum

207.76B

Amgen Inc. (AMGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amgen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 29.47%

Maximum Annual Enterprise Value = 207.76B

Minimum Annual Increase = -6.47%

Minimum Annual Enterprise Value = 140.72B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023207.76B20.36%
2022172.62B12.41%
2021153.55B-4.89%
2020161.45B-4.87%
2019169.71B9.03%
2018155.66B-1.89%
2017158.66B12.75%
2016140.72B-6.47%
2015150.46B1.74%
2014147.89B29.47%

Amgen Inc. (AMGN) Average Enterprise Value

How has AMGN Enterprise Value performed in the past?

The current Enterprise Value of Amgen Inc. (AMGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

177.98B

5-year avg

173.02B

10-year avg

161.85B

Amgen Inc. (AMGN) Enterprise Value vs. Peers

How is AMGN’s Enterprise Value compared to its peers?

Amgen Inc.’s Enterprise Value is less than Merck & Co., Inc. (362.03B), less than AbbVie Inc. (361.13B), greater than Gilead Sciences, Inc. (109.62B), less than Johnson & Johnson (365.02B), greater than Bristol-Myers Squibb Company (133.12B), less than Pfizer Inc. (226.72B), less than Eli Lilly and Company (866.75B), greater than Biogen Inc. (38.64B),

CompanyEnterprise ValueMarket cap
362.03B$333.48B
361.13B$305.20B
109.62B$89.14B
365.02B$356.86B
133.12B$85.04B
226.72B$157.90B
866.75B$842.99B
38.64B$32.77B

Build a custom stock screener for Amgen Inc. (AMGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amgen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amgen Inc. (AMGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amgen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amgen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Amgen Inc. (AMGN)?

What is the 3-year average Enterprise Value for Amgen Inc. (AMGN)?

What is the 5-year average Enterprise Value for Amgen Inc. (AMGN)?

How does the current Enterprise Value for Amgen Inc. (AMGN) compare to its historical average?